celiprolol has been researched along with Cardiac Hypertrophy in 4 studies
Celiprolol: A cardioselective beta-1 adrenergic antagonist that has intrinsic sympathomimetic activity. It is used in the management of ANGINA PECTORIS and HYPERTENSION.
Cardiac Hypertrophy: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.
| Excerpt | Relevance | Reference |
|---|---|---|
| "These findings indicated that celiprolol attenuates cardiac myocyte hypertrophy both in vitro and in vivo and halts the process leading from hypertrophy to heart failure." | 7.72 | Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice. ( Asakura, M; Asano, Y; Asanuma, H; Hori, M; Kim, J; Kitakaze, M; Kitamura, S; Liao, Y; Minamino, T; Ogai, A; Sanada, S; Shintani, Y; Takashima, S; Tomoike, H, 2004) |
| "These findings indicated that celiprolol attenuates cardiac myocyte hypertrophy both in vitro and in vivo and halts the process leading from hypertrophy to heart failure." | 3.72 | Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice. ( Asakura, M; Asano, Y; Asanuma, H; Hori, M; Kim, J; Kitakaze, M; Kitamura, S; Liao, Y; Minamino, T; Ogai, A; Sanada, S; Shintani, Y; Takashima, S; Tomoike, H, 2004) |
| "Long-term treatment with celiprolol, a new cardioselective beta blocker, significantly reduced blood pressure in 14 patients with essential hypertension (World Health Organization stages I to II)." | 3.67 | Reduction of left ventricular hypertrophy in hypertensive patients after treatment with celiprolol. ( Bischof, F; Burghagen, H; Freischuetz, G; Herrmann, JM; Mayer, EO; Von Heymann, F, 1988) |
| "Celiprolol (C) is a new selective beta 1-blocker with partial beta 2-agonistic activity." | 1.28 | Short-term effects of celiprolol on blood pressure and left ventricular performance in hypertensive cardiomyopathy. ( Alay, D; Cuenca, P; Lorenzo, JG; Plaza, L; RodrÃguez Rodrigo, FJ; Ruiz, I; Terol, I, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liao, Y | 1 |
| Asakura, M | 1 |
| Takashima, S | 1 |
| Ogai, A | 1 |
| Asano, Y | 1 |
| Shintani, Y | 1 |
| Minamino, T | 1 |
| Asanuma, H | 1 |
| Sanada, S | 1 |
| Kim, J | 1 |
| Kitamura, S | 1 |
| Tomoike, H | 1 |
| Hori, M | 1 |
| Kitakaze, M | 1 |
| RodrÃguez Rodrigo, FJ | 1 |
| Ruiz, I | 1 |
| Lorenzo, JG | 1 |
| Alay, D | 1 |
| Terol, I | 1 |
| Cuenca, P | 1 |
| Plaza, L | 1 |
| Vyssoulis, GP | 1 |
| Karpanou, EA | 1 |
| Pitsavos, CE | 1 |
| Kourtis, TK | 1 |
| Paleologos, AA | 1 |
| Toutouzas, PK | 1 |
| Herrmann, JM | 1 |
| Bischof, F | 1 |
| Von Heymann, F | 1 |
| Mayer, EO | 1 |
| Freischuetz, G | 1 |
| Burghagen, H | 1 |
4 other studies available for celiprolol and Cardiac Hypertrophy
| Article | Year |
|---|---|
Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Cardiomegaly; Celiprol | 2004 |
Short-term effects of celiprolol on blood pressure and left ventricular performance in hypertensive cardiomyopathy.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Cardiomegaly; Celiprolol; Echocardiography, Doppler; Fe | 1992 |
Comparison of ketanserin and celiprolol on regression of left ventricular hypertrophy in older hypertensive patients.
Topics: Adrenergic beta-Antagonists; Aged; Blood Pressure; Cardiomegaly; Celiprolol; Echocardiography; Femal | 1992 |
Reduction of left ventricular hypertrophy in hypertensive patients after treatment with celiprolol.
Topics: Adult; Antihypertensive Agents; Cardiomegaly; Celiprolol; Echocardiography; Female; Humans; Hyperten | 1988 |